Abstract
The enzyme telomerase is essential for cell proliferation and tumorigenesis. Telomerase reverse transcriptase (TERT) represents the catalytic subunit of the enzyme. In humans, TERT expression is regulated by several different mechanisms, including alternative splicing. Canis familiaris TERT (dogTERT) has been shown to have a high level of sequence similarity with human TERT, indicating that the dog may represent a suitable animal model for telomerase studies. In the present report we sought to investigate whether dogTERT undergoes alternative splicing. During the analysis of canine mammary tissues (both tumor and paired adjacent to the tumor normal tissues) for dogTERT expression by RT-PCR, we identified eight samples—one tumor and seven adjacent normal—which gave PCR products of unexpected sizes. DNA sequencing revealed two insertions (175 and 28 bp long) and two deletions (17 and 32 bp long), which were encountered in different combinations and gave rise to five different transcripts. The generation of all variants could be explained by the employment of alternative splicing sites within dogTERT genomic sequences. The 175-bp and 28-bp insertions, identified between exons 7 and 8 and between 8 and 9, respectively, constituted unspliced sequences of introns 7 and 8, respectively. Both deletions originated from exon 8 sequence removals due to alternative splicing. All five variants encoded truncated proteins, which lacked essential motifs for reverse transcription and might have thus lost their ability to compose active telomerase enzymes. This is the first identification of alternative splicing events within dogTERT. The results presented here may provide the basis for more thorough studies on the regulation of telomerase activity in canine normal and cancer cells.
Similar content being viewed by others
References
Angelopoulou K, Spiropoulou T, Stathopoulou A, Dimitropoulos D, Malamos N et al (2003) Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse-transcriptase beta-plus transcript. Anticancer Res 23:4821–4830
Argyle DJ, Nasir L (2003) Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Vet Pathol 40:1–7
Bodnar A, Ouellette M, Frolkis M, Holt S, Chiu C et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352
Colgin L, Wilkinson C, Englezou A, Kilian A, Robinson M et al (2000) The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426–432
Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N et al (2000) Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 37:177–183
Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA (1999) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Mol Cell Biol 19:3989–3997
Hahn W, Counter C, Lundberg A, Beijersbergen R, Brooks M et al (1999) Creation of human tumor cells with defined genetic elements. Nature 400:464–468
Hisatomi H, Ohyashiki K, Ohyashiki JH, Nagao K, Kanamaru T et al (2003) Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 5:193–197
Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ et al (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011–2019
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015
Lindblad-Toh K, Birren B, Nusbaum C, Abebe A, Abouelleil A et al (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803–819
Mavrogiannou E, Strati A, Stathopoulou A, Tsaroucha EG, Kaklamanis L et al (2007) Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer. Clin Chem 53:53–61
Meyerson M, Counter CM, Eaton EM, Ellisen LW, Steiner P et al (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785–795
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH et al (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955–959
Nasir L (2008) Telomeres and telomerase: biological and clinical importance in dogs. Vet J 175:155–163
Nasir L, Devlin P, McKevitt T, Rutteman G, Argyle DJ (2001) Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology. Neoplasia 3:351–359
Nasir L, Gault E, Campbell S, Veeramalai M, Gilbert D et al (2004) Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT). Gene 336:105–113
Poole JC, Andrews LG, Tollefsbol TO (2001) Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269:1–12
Quinnell RJ, Courtenay O, Shaw MA, Day MJ, Garcez LM et al (2001) Tissue cytokine responses in canine visceral leishmaniasis. J Infect Dis 183:1421–1424
Renwick MG, Argyle DJ, Long S, Nixon C, Gault EA et al (2006) Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: correlation with Ki67 immunoreactivity. Vet Comp Oncol 4:141–150
Sæbøe-Larssen S, Fossberg E, Gaudernack G (2006) Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol 7:26
Shapiro MB, Senepathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155–7174
Shay J, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787–791
Spiropoulou T, Ferekidou L, Angelopoulou K, Stathopoulou A, Talieri M et al (2004) Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells. Clin Biochem 37:299–304
Ulaner G, Hu JF, Vu T, Giudice L, Hoffmann A (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168–4172
Ulaner AG, Ji-F Hu, Vu HT, Oruganti H, Giudice CL et al (2000) Regulation of telomerase by alternative splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85:330–335
Weitzman J, Yaniv M (1999) Rebuilding the road to cancer. Nature 400:401–402
Wick M, Zubov D, Hagen G (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232:97–106
Yazawa M, Okuda M, Setoguchi A, Nishimura R, Sasaki N et al (1999) Measurement of telomerase activity in dog tumors. J Vet Med Sci 61:1125–1129
Yazawa M, Okuda M, Setoguchi A, Iwabuchi S, Nishimura R et al (2001) Telomere length and telomerase activity in canine mammary gland tumors. Am J Vet Res 62:1539–1543
Yi X, Shay JW, Wright WE (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29:4818–4825
Zaffaroni N, Della Porta C, Villa R, Botti C, Buglioni S et al (2002) Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity. J Pathol 198:37–46
Author information
Authors and Affiliations
Corresponding author
Additional information
dogTERT alternatively spliced transcripts identified in this study are available in GenBank under accession numbers EU126889-EU126894.
Rights and permissions
About this article
Cite this article
Angelopoulou, K., Zavlaris, M., Papaioannou, N. et al. Canis familiaris telomerase reverse transcriptase undergoes alternative splicing. Mamm Genome 19, 647–653 (2008). https://doi.org/10.1007/s00335-008-9144-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-008-9144-7